Peringkat dalam Saham
#37511
Amniotics AB (publ) specializes in the creation, manufacturing, and... Amniotics AB (publ) specializes in the creation, manufacturing, and commercialization of stem cell-based therapies, utilizing mesenchymal stem cells to address critical, life-threatening illnesses. The company's primary therapeutic candidate, PulmoStem, is designed for the treatment of inflammatory and fibrotic conditions affecting the lungs. Furthermore, Amniotics is advancing other promising treatments such as CogniStem for neurological disorders, NephroStem for kidney-specific ailments, and CutiStem for various dermatological issues. Beyond its own pipeline, the firm provides contract development and manufacturing services for advanced therapy medicinal products to pharmaceutical companies, universities, and hospitals. Established in 2015, Amniotics AB is headquartered in Lund, Sweden.
Harga Saham
$0.00060315
Terakhir disinkronkan: 2024-09-27
Kapitalisasi Pasar
$1.65M
Perubahan (1 hari)
19.64%
Perubahan (1 tahun)
0.00%
Perdagangan Amniotics AB (publ) (AMNI)
Harga AMNI dengan kapitalisasi pasar B
Kapitalisasi pasar dari Amniotics AB (publ)(AMNI)
Kapitalisasi Pasar: $1.65M
Per August 2026, Amniotics AB (publ) memiliki kapitalisasi pasar sebesar $1.65M. Ini menjadikan Amniotics AB (publ) sebagai perusahaan 37511th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Amniotics AB (publ) dari 2021 hingga 2026
AMNI dibandingkan dengan 5 teratas stocks paling populer
| Harga AMNI |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.452T
|
+330,719,226.46%
|
|
|
|
|
$4.490T
|
+272,371,960.14%
|
|
|
|
|
$4.162T
|
+252,498,403.81%
|
|
|
|
|
$3.676T
|
+223,012,921.38%
|
|
|
|
|
$2.833T
|
+171,856,957.95%
|
